Relyea Zuckerberg Hanson’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,256
| Closed | -$295K | – | 237 |
|
|
2024
Q1 | $295K | Sell |
10,256
-1,405
| -12% | -$40.4K | 0.05% | 184 |
|
|
2023
Q4 | $383K | Buy |
11,661
+1,220
| +12% | +$40K | 0.07% | 139 |
|
|
2023
Q3 | $291K | Buy |
10,441
+762
| +8% | +$21.2K | 0.07% | 150 |
|
|
2023
Q2 | $330K | Sell |
9,679
-1,808
| -16% | -$61.6K | 0.07% | 138 |
|
|
2023
Q1 | $345K | Hold |
11,487
| – | – | 0.08% | 125 |
|
|
2022
Q4 | $324K | Buy |
+11,487
| New | +$324K | 0.09% | 126 |
|
|
2022
Q2 | – | Sell |
-6,619
| Closed | -$292K | – | 142 |
|
|
2022
Q1 | $292K | Sell |
6,619
-6,683
| -50% | -$295K | 0.1% | 131 |
|
|
2021
Q4 | $620K | Buy |
13,302
+2,988
| +29% | +$139K | 0.22% | 78 |
|
|
2021
Q3 | $771K | Sell |
10,314
-6,098
| -37% | -$456K | 0.3% | 55 |
|
|
2021
Q2 | $1.52M | Buy |
16,412
+222
| +1% | +$20.5K | 0.62% | 29 |
|
|
2021
Q1 | $1.49M | Buy |
16,190
+4,068
| +34% | +$375K | 0.66% | 28 |
|
|
2020
Q4 | $1.13M | Buy |
12,122
+2,228
| +23% | +$208K | 0.61% | 32 |
|
|
2020
Q3 | $721K | Buy |
9,894
+823
| +9% | +$60K | 0.46% | 42 |
|
|
2020
Q2 | $473K | Buy |
9,071
+235
| +3% | +$12.3K | 0.38% | 59 |
|
|
2020
Q1 | $276K | Hold |
8,836
| – | – | 0.3% | 79 |
|
|
2019
Q4 | $296K | Buy |
+8,836
| New | +$296K | 0.28% | 84 |
|